FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088550873> ?p ?o ?g. }

• W3088550873 endingPage "9085" @default.
• W3088550873 startingPage "9077" @default.
• W3088550873 abstract "Hepatic metastasis of colon carcinoma seriously affects the prognosis of patients, and miRNA has attracted much attention in predicting hepatic metastasis of colon carcinoma (CC). This research aimed to explore the predictive role of miR-210 in serum for recurrence and prognosis of CC patients with hepatic metastasis.Altogether, 150 patients with liver metastases of CC (research group, RG) and 130 patients with non-metastatic of CC (control group, CG) admitted to People's Hospital of Deyang City from March 2012 to March 2015 were obtained and their serum was collected. miR-210 in the RG and the CG, and miR-210 in the RG after radiofrequency ablation treatment were detected, the relationship between miR-210 and pathological parameters of CC patients with hepatic metastasis was analyzed, and patients in the RG were followed up for 5 years to analyze the recurrence, overall survival (OS) and disease-free survival (DFS). The area under the curve (AUC) of receiver operating characteristic curve (ROC) was applied to test the predictive value of miR-210. Cox regression was applied to analyze the independent prognostic factors of patients.miR-210 in the RG was evidently higher than that in the CG, and AUC for distinguishing hepatic metastasis of CC was 0.907. miR-210 had a close correlation with lymph node metastasis, distant metastasis and pathological differentiation. After treatment, miR-210 in the RG was evidently reduced, and the serum was higher in patients with recurrence and with poor prognosis. AUC for predicting recurrence was 0.858, and AUC for predicting poor prognosis was 0.843. High miR-210 was closely related to lower 5-year OS and DFS and is also an independent prognostic factor affecting patients' 5-year OS.miR-210 is enhanced in hepatic metastasis of CC, which is a serological biomarker for predicting recurrence and prognosis of patients with hepatic metastasis of CC after radiofrequency ablation, and has great clinical application value." @default.
• W3088550873 created "2020-10-01" @default.
• W3088550873 creator A5005900354 @default.
• W3088550873 creator A5006382294 @default.
• W3088550873 creator A5030202096 @default.
• W3088550873 creator A5077363240 @default.
• W3088550873 date "2020-09-01" @default.
• W3088550873 modified "2023-09-27" @default.
• W3088550873 title "<p>miR-210 is a Serological Biomarker for Predicting Recurrence and Prognosis of Colon Carcinoma Patients with Liver Metastases After Radiofrequency Ablation Treatment</p>" @default.
• W3088550873 cites W1992749719 @default.
• W3088550873 cites W2004333139 @default.
• W3088550873 cites W2028480045 @default.
• W3088550873 cites W2066779145 @default.
• W3088550873 cites W2097540972 @default.
• W3088550873 cites W2110402883 @default.
• W3088550873 cites W2153574471 @default.
• W3088550873 cites W2162942697 @default.
• W3088550873 cites W2187651642 @default.
• W3088550873 cites W2274827638 @default.
• W3088550873 cites W2296354054 @default.
• W3088550873 cites W2338011571 @default.
• W3088550873 cites W2413279306 @default.
• W3088550873 cites W2422389964 @default.
• W3088550873 cites W2509616816 @default.
• W3088550873 cites W2510987247 @default.
• W3088550873 cites W2526759073 @default.
• W3088550873 cites W2532556840 @default.
• W3088550873 cites W2550568446 @default.
• W3088550873 cites W2784695928 @default.
• W3088550873 cites W2890210379 @default.
• W3088550873 cites W2892004398 @default.
• W3088550873 cites W2898134115 @default.
• W3088550873 cites W2903108737 @default.
• W3088550873 cites W2904323592 @default.
• W3088550873 cites W2907758632 @default.
• W3088550873 cites W2940642032 @default.
• W3088550873 cites W2969612538 @default.
• W3088550873 cites W2971163727 @default.
• W3088550873 cites W2998673845 @default.
• W3088550873 cites W3014529952 @default.
• W3088550873 doi "https://doi.org/10.2147/cmar.s267731" @default.
• W3088550873 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7524199" @default.
• W3088550873 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33061602" @default.
• W3088550873 hasPublicationYear "2020" @default.
• W3088550873 type Work @default.
• W3088550873 sameAs 3088550873 @default.
• W3088550873 citedByCount "4" @default.
• W3088550873 countsByYear W30885508732021 @default.
• W3088550873 countsByYear W30885508732022 @default.
• W3088550873 crossrefType "journal-article" @default.
• W3088550873 hasAuthorship W3088550873A5005900354 @default.
• W3088550873 hasAuthorship W3088550873A5006382294 @default.
• W3088550873 hasAuthorship W3088550873A5030202096 @default.
• W3088550873 hasAuthorship W3088550873A5077363240 @default.
• W3088550873 hasBestOaLocation W30885508731 @default.
• W3088550873 hasConcept C121608353 @default.
• W3088550873 hasConcept C126322002 @default.
• W3088550873 hasConcept C143998085 @default.
• W3088550873 hasConcept C185592680 @default.
• W3088550873 hasConcept C207886595 @default.
• W3088550873 hasConcept C2777377203 @default.
• W3088550873 hasConcept C2778019345 @default.
• W3088550873 hasConcept C2778902805 @default.
• W3088550873 hasConcept C2779013556 @default.
• W3088550873 hasConcept C2781197716 @default.
• W3088550873 hasConcept C50382708 @default.
• W3088550873 hasConcept C526805850 @default.
• W3088550873 hasConcept C55493867 @default.
• W3088550873 hasConcept C58471807 @default.
• W3088550873 hasConcept C71924100 @default.
• W3088550873 hasConcept C90924648 @default.
• W3088550873 hasConceptScore W3088550873C121608353 @default.
• W3088550873 hasConceptScore W3088550873C126322002 @default.
• W3088550873 hasConceptScore W3088550873C143998085 @default.
• W3088550873 hasConceptScore W3088550873C185592680 @default.
• W3088550873 hasConceptScore W3088550873C207886595 @default.
• W3088550873 hasConceptScore W3088550873C2777377203 @default.
• W3088550873 hasConceptScore W3088550873C2778019345 @default.
• W3088550873 hasConceptScore W3088550873C2778902805 @default.
• W3088550873 hasConceptScore W3088550873C2779013556 @default.
• W3088550873 hasConceptScore W3088550873C2781197716 @default.
• W3088550873 hasConceptScore W3088550873C50382708 @default.
• W3088550873 hasConceptScore W3088550873C526805850 @default.
• W3088550873 hasConceptScore W3088550873C55493867 @default.
• W3088550873 hasConceptScore W3088550873C58471807 @default.
• W3088550873 hasConceptScore W3088550873C71924100 @default.
• W3088550873 hasConceptScore W3088550873C90924648 @default.
• W3088550873 hasLocation W30885508731 @default.
• W3088550873 hasLocation W30885508732 @default.
• W3088550873 hasLocation W30885508733 @default.
• W3088550873 hasLocation W30885508734 @default.
• W3088550873 hasOpenAccess W3088550873 @default.
• W3088550873 hasPrimaryLocation W30885508731 @default.
• W3088550873 hasRelatedWork W2015664946 @default.
• W3088550873 hasRelatedWork W2046647309 @default.
• W3088550873 hasRelatedWork W2083674344 @default.
• W3088550873 hasRelatedWork W2156133006 @default.
• W3088550873 hasRelatedWork W2315143391 @default.

• next